Scientific Committee Members of Targeting Phage Therapy
 |
Ms. Barbara Brenner, Kanzlei BRENNER, Germany |
 |
Prof. Domenico Frezza, University of Roma Tor Vergata, Italy |
 |
Prof. Robert Schooley, University of California San Diego, USA |
 |
Dr. Daniel De Vos, |
 |
Dr. Mariagrazia Di Luca,
|
 |
Prof. Marvin Edeas, |
 |
Dr. Ekaterina Chernevskaya, Federal research and clinical center of intensive care medicine and rehabilitology, Russia |
 |
Dr. Mzia Kutateladze, |
 |
Dr. Anders Nilsson, |
 |
Dr. Jean-Paul Pirnay, |
 |
Dr. Anna Pistocchi, |
 |
Dr. Brieuc Van Nieuwenhuyse, |
 |
Dr. Atonia P. Sagona, |
 |
Dr. Nannan Wu, |
 |
Dr. Jumpei Fujiki |
Scientific Committee Members of Phage Therapy 2024
 |
Ms. Barbara Brenner, Kanzlei BRENNER, Germany |
|
Prof. Domenico Frezza, University of Roma Tor Vergata, Italy |
|
Prof. Robert Schooley, University of California San Diego, USA |
|
Dr. Daniel De Vos, Queen Astrid Military Hospital, Belgium |
|
Dr. Mariagrazia Di Luca, University of Pisa, Italy |
|
Prof. Marvin Edeas, INSERM – Institut Cochin, Université de Paris, France |
 |
Dr. Ekaterina Chernevskaya, |
|
Dr. Mzia Kutateladze, Director of G. Eliava Institute of Bacteriophages, Microbiology and Virology, Georgia
|
|
Dr. Anders Nilsson, Stockholm University, Sweden |
|
Dr. Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium |
|
Dr. Anna Pistocchi, Università degli Studi di Milano, Italy |
|
Dr. Brieuc Van Nieuwenhuyse, UCLouvain, Belgium |
|
Dr. Atonia P. Sagona, University of Warwick, United Kingdom |
|
Dr. Nannan Wu, Shanghai Public Health Clinical Center, China |
|
Dr. Jumpei Fujiki Rakuno Gakuen University, Japan |